Anugerah 88

0.22

-0.03

|(-12.00%)

52W H: 0.5452W L: 0.15Beta: -0.05

About Guided Therapeutics Inc

Industry: Health Care
Exchange: OTC MARKETS
Country: US
Website: https://www.guidedinc.com/

Frequently Asked Questions

What is the 52-week range for GTHP?

The 52-week high is $0.54 and the 52-week low is $0.15.

What is the P/E ratio for GTHP?

The P/E ratio data is currently unavailable.

What is the dividend yield for GTHP?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -471.48%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -361.28%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 37.42.

Latest GTHP News

Guided Therapeutics Reaches Collaborative Agreement with Türkiye’s Ministry of Health to Become Primary Screening Test for Cervical Cancer

PEACHTREE CORNERS, Ga., September 09, 2026--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that it has reached an agreement with the Ministry of Health to co-develop LuViva for primary screening of cervical cancer in Türkiye. The first step of the collaborative agreement is to conduct an 800 patient clinical study to optimize LuViva’s AI pattern recognition algorithms for real time detection of cellular changes that occur in the earliest stages

Yahoo9/9/2026

Related Stocks (Peers)

Companies operating in similar sectors to GTHP:

GIPL BEAT PAVM RDGL GTHP ICU HSCS CVB.AX FEMY MODD ABT

Recent Insider Transactions

Date	Name	Shares Changed	Price	Value
2026-03-31	Imhoff John E	-157,417	$0.07	$11,019
2026-03-31	Imhoff John E	+157,417	$0.07	$11,019
2026-03-26	Blumberg Richard P.	+352,000	-	-
2026-03-26	Blumberg Richard P.	-88	-	-
2026-03-26	Blumberg Richard P.	+19,038	-	-
2026-03-26	Blumberg Richard P.	+1,040,000	-	-
2026-03-26	Blumberg Richard P.	-260	-	-
2026-03-26	Blumberg Richard P.	+56,093	-	-
2026-03-26	Imhoff John E	+40,000	-	-
2026-03-26	Imhoff John E	-10	-	-
2026-03-26	Imhoff John E	+2,157	-	-
2026-03-10	Blumberg Richard P.	+110,000	-	-
2026-03-10	Grujic Alan	+110,000	-	-
2026-03-10	JAMES MICHAEL C	+110,000	-	-
2026-03-10	Imhoff John E	+110,000	-	-
2026-03-01	Blumberg Richard P.	-900,000	$0.3	$270,000
2026-02-27	Imhoff John E	-156,086	$0.07	$10,926
2026-02-27	Imhoff John E	+156,086	$0.07	$10,926
2026-02-27	Imhoff John E	+400,000	-	-
2026-02-27	Imhoff John E	-100	-	-
2026-02-25	Blumberg Richard P.	-1,000,000	$0.2	$200,000
2026-02-25	Blumberg Richard P.	+1,000,000	-	-
2026-02-25	Blumberg Richard P.	-1,000,000	-	-
2026-02-25	Blumberg Richard P.	+1,000,000	-	-
2026-02-25	Blumberg Richard P.	-1,000,000	-	-
2026-02-25	Blumberg Richard P.	+1,000,000	-	-
2026-02-25	Imhoff John E	-500,000	-	-
2026-02-25	Imhoff John E	+500,000	-	-
2026-02-25	Imhoff John E	-500,000	-	-
2026-02-25	Imhoff John E	+500,000	-	-
2026-02-25	Imhoff John E	-500,000	-	-
2026-02-25	Imhoff John E	+500,000	-	-
2026-02-25	JAMES MICHAEL C	-100,000	-	-
2026-02-25	JAMES MICHAEL C	+100,000	-	-
2026-02-25	JAMES MICHAEL C	-100,000	-	-
2026-02-25	JAMES MICHAEL C	+100,000	-	-
2026-02-25	JAMES MICHAEL C	-100,000	-	-
2026-02-25	JAMES MICHAEL C	+100,000	-	-
2026-02-02	Imhoff John E	-312,720	-	-
2026-02-02	Imhoff John E	+312,720	$0.07	$21,890
2026-01-05	Imhoff John E	+25,338	-	-
2025-12-18	Imhoff John E	-195,460	-	-
2025-12-18	Imhoff John E	+195,460	$0.07	$13,682